Importance of apolipoproteins in lipid metabolism

Chemico-Biological Interactions

Volumn 20, Issue 3, 1978, Pages 263-277

  Cham, Bill Elliot ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN;

HYPERLIPIDEMIA; LIPID METABOLISM;

APOLIPOPROTEINS; CHYLOMICRONS; HUMAN; INTESTINES; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LIVER;

EID: 0017863396     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-2797(78)90105-9     Document Type: Review

References (87)

1. Studies of the composition and structure of serum lipoproteins. Isolation and characterization of very high density lipoproteins of human serum
2. On the nature of prebeta lipoproteins
3. Effects of ultracentrifugation of the human serum high density (1.063 < d < 1.21 g/ml) lipoprotein
4. 125I-labeled lipoproteins with specific polypeptide antisera, Evidence for two populations with differing polypeptide compositions in human high density lipoproteins
5. Selective loss of apolipoproteins upon ultracentrifugation of very low density lipoproteins (VLDL)
6. Fat transport in lipoproteins — an integrated approach to mechanisms and disorders
7. Fat transport in lipoproteins — an integrated approach to mechanisms and disorders
8. Fat transport in lipoproteins — an integrated approach to mechanisms and disorders
9. Fat transport in lipoproteins — an integrated approach to mechanisms and disorders
10. Fat transport in lipoproteins — an integrated approach to mechanisms and disorders
11. Classification of hyperlipidemias and hyperlipoproteinemias
12. The structure and metabolism of chylomicrons and very low density lipoproteins (VLDL)
13. Lipid composition of lipoproteins in normal and diseased states
14. Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine
15. Identity of very low density lipoprotein apoproteins of plasma and liver Golgi apparatus
16. Lipoprotein associated with the Golgi apparatus isolated from epithelial cells of rat small intestine
17. Synthesis and secretion of plasma lipoproteins
18. Relationship between plasma triglycerides and removal of chylomicrons
19. Studies on the metabolism of plasma proteins in the nephrotic syndrome, II, The lipoproteins
20. Very low density lipoprotein metabolism in abetalipoproteinemia
21. Comparison of turnover of individual cholesterol esters in subjects with low and high plasma cholesterol concentration
22. Effect of clofibrate on low-density lipoprotein turnover in essential hypercholesterolaemia
23. The effect of ethyl chlorophenoxyisobutyrate (CPIB) on the uptake of triglyceride fatty acids, activity of lipoprotein lipase and lipogenisis from glucose in fat tissue of rats
24. The effect of ethyl p-chlorophenoxyisobutyrate (CPIB) on adipose tissue lipoprotein lipase activity
25. Effect of treatment with nicotinic acid for one month on serum lipids with different types of hyperlipidemia
26. Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinemia
27. Studies on low-density lipoprotein turnover in relation to atromid therapy
28. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia
29. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts: comparisons of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia
30. Handb. Exp. Pharmakol.
31. Properties of human serum low density lipoprotein after modification by succinic anhydride
32. Subunit heterogeneity in human serum beta lipoprotein
33. Determination of the molecular weight of apoprotein subunits from low density lipoprotein by Gel Filtration
34. The protein moiety of human serum betalipoproteins
35. The size and number of polypeptide chains in human serum low density lipoproteins
36. Subunit structure of the apoprotein of human serum low density lipoprotein
37. Studies on the structure of lipoprotein-B. Lipid-Protein complexes
38. Protein denaturation: Characterization of the denatured state and transition from native to denatured state
39. Molecular weight estimations of polypeptide chains by electrophoresis in SDS-polyacrylamide gels
40. The reliability of molecular weight determinations by dodecyl sulphate-polyacrylamide gel electrophoresis
41. Insolubility of the protein moiety of human plasma low-density lipoproteins, Lipid-protein complexes
42. A solvent system for delipidation of plasma or serum without protein precipitation
43. Changes in electrophoretic mobilities of α- and β-lipoproteins as a result of plasma delipidation
44. In vitro partial relipidation of apolipoproteins in plasma
45. 2+
46. In vitro interactions of phenformin with serum lipoproteins and consequences thereof
47. The effect of phenformin and heparin on serum lipoproteins
48. Quantitative determination of human apolipoprotein D. by electroimmunoassay and radial immunodiffusion
49. Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment
50. The effect of nicotinic acid on the plasma free fatty acids, Demonstration of a metabolic type of sympathicolysis
51. Hypercholesteremia and Nicotinic Acid
52. The current status of hypolipidemic drugs
53. 14 by rat liver mitochondria, Effect of Nicotinic acid
54. Effect of nicotinic acid and related compounds on incorporation of mevalonic acid into cholesterol
55. Reduction of serum cholesterol by sodium dextrothyroxine
56. Influence of thyroid on the synthesis of cholesterol by liver and skin in vitro
57. Cholic-acid turnover and biliary bile-acid composition in humans with abnormal thyroid function
58. Lipid lowering drugs and hyperlipidemia
59. Mechanism of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia
60. Effects of α-p-chlorophenoxyisobutyryl ethyl ester (CPIB) with and without androsterone on cholesterol biosynthesis in rat liver
61. Plasma cholesterol and lowering action of bile acid binding polymers in experimental animals
62. Cholestyramine resin therapy for hypercholesteremia, clinical and metabolic studies
63. 14C cholesterol: v obligatory function of bile in intestinal absorption of cholesterol
64. The metabolism of cholesterol in two hypercholesterolemic patients treated with cholestyramine
65. Combined use of clofibrate and cholestyramine or DEAE Sephadex in hypercholesterolaemia
66. Colestipol and cholestyramine Resin, Comparative effects in familial Type II hyperlipoproteinemia
67. Role of plasma lecithin: Cholesterol acyltransferase in the metabolism of high density lipoproteins
68. Purification and substrate specificity of lecithin—cholesterol acyltransferase from human plasma
69. The metabolic role of lecithincholesterol acyltransferase perspectives from pathology
70. Plasma lipoproteins in familial lecithin; cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro
71. The lipoproteins of human serum
72. Plasma lipoprotein metabolism in perfused rat livers, II. Transfer of free and esterified cholesterol into the plasma
73. Separation and characterization of the protein moiety of human α-lipoprotein
74. The protein subunit of human serum lipoproteins of density 1.125-1.200 g/ml
75. Modification of human serum lipoprotein fractions by lipide extraction
76. Etude des alpha-lipoprotéine sériques humaines par immunoelectrophorése
77. Mise en évidence et séparation des constituants protéiniques des alpha lipoprotéines du sérum humain
78. Studies on human serum high density lipoproteins, self-association of apolipoprotein A-1 in aqueous solutions
79. Purification and characterization of human plasma lecithin: cholesterol acyltransferase
80. Studies of the composition and structure of human serum lipoproteins, isolation and partial characterization of apolipoproteins AIII
81. Effects of androgens and estrogens on serum lipids and the composition and concentration of serum lipoproteins in normolipemic and hyperlipidemic states
82. Studies of the metabolism of radioiodinated human serum alpha lipoprotein in normal and hyperlipidemic subjects
83. Change in serum lipids and urinary ketosteroids during oral and intramuscular administration of androsterone
84. Hypolipidemic drugs
85. Inhibition of lipid biosyntheses
86. The metabolic basis of inherited disease